Literature DB >> 17235437

Microarray analysis reveals the role of matrix metalloproteinases in mouse experimental autoimmune myocarditis induced by cardiac myosin peptides.

Qizhu Tang1, Ji Huang, Haiyan Qian, Ran Xiong, Difei Shen, Hui Wu, Zhouyan Bian, Xiaohong Wei.   

Abstract

Autoimmune myocarditis develops after the presentation of heart-specific antigens to autoaggressive CD4(+) T cells and after inflammation has infiltrated the tissues. To shed light on global changes in the gene expression of autoimmune myocarditis and to gain further insight into the molecular mechanisms underlying the genesis of myocarditis, we conducted a comprehensive microarray analysis of mRNA using an experimental mouse autoimmune myocarditis model via immunization with alpha-myosin heavy chain-derived peptides. Of over 39,000 transcripts on a high density oligonucleotide microarray, 466 were under-expressed and 241 over-expressed by >or= 1.5-fold compared with the controls in BALB/C mouse with autoimmune myocarditis. In this paper, we list the top 50 up-regulated genes related to the immune response. These altered genes encode for leukocyte-specific markers and receptors, the histocompatibility complex, cytokines/receptors, chemokines/receptors, adhesion molecules, components of the complement cascade, and signal transduction-related molecules. Interestingly, matrix metalloproteinases (MMPs) such as MMP-3 and MMP-9 were up-regulated, as further revealed by the reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemistry assays. This indicates that MMPs may act as major regulators of the cytokine profile. Together, these findings provide new insight into the molecular events associated with the mechanism of the autoimmune genesis of myocarditis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17235437      PMCID: PMC6275600          DOI: 10.2478/s11658-007-0003-4

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


  33 in total

1.  Altered patterns of gene expression in response to myocardial infarction.

Authors:  L W Stanton; L J Garrard; D Damm; B L Garrick; A Lam; A M Kapoun; Q Zheng; A A Protter; G F Schreiner; R T White
Journal:  Circ Res       Date:  2000-05-12       Impact factor: 17.367

2.  Enterovirus-induced production of pro-inflammatory and T-helper cytokines by human leukocytes.

Authors:  G R Vreugdenhil; P G Wijnands; M G Netea; J W van der Meer; W J Melchers; J M Galama
Journal:  Cytokine       Date:  2000-12       Impact factor: 3.861

3.  Evaluation of the effects of 17beta-estradiol (17beta-e2) on gene expression in experimental autoimmune encephalomyelitis using DNA microarray.

Authors:  Agata Matejuk; Jami Dwyer; Alex Zamora; Arthur A Vandenbark; Halina Offner
Journal:  Endocrinology       Date:  2002-01       Impact factor: 4.736

4.  Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.

Authors:  C V Thomas; M L Coker; J L Zellner; J R Handy; A J Crumbley; F G Spinale
Journal:  Circulation       Date:  1998-05-05       Impact factor: 29.690

5.  Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy.

Authors:  B J Aronow; T Toyokawa; A Canning; K Haghighi; U Delling; E Kranias; J D Molkentin; G W Dorn
Journal:  Physiol Genomics       Date:  2001-06-06       Impact factor: 3.107

Review 6.  Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?

Authors:  E E Creemers; J P Cleutjens; J F Smits; M J Daemen
Journal:  Circ Res       Date:  2001-08-03       Impact factor: 17.367

7.  Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction.

Authors:  A Ducharme; S Frantz; M Aikawa; E Rabkin; M Lindsey; L E Rohde; F J Schoen; R A Kelly; Z Werb; P Libby; R T Lee
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

8.  Cardiac myosin induces myocarditis in genetically predisposed mice.

Authors:  N Neu; N R Rose; K W Beisel; A Herskowitz; G Gurri-Glass; S W Craig
Journal:  J Immunol       Date:  1987-12-01       Impact factor: 5.422

9.  An ultrastructural study on experimental autoimmune myocarditis with special reference to effector cells.

Authors:  T Izumi; K Suzuki; M Saeki; Y Ookura; S Hirono; T Inomata; H Hanawa; M Kodama
Journal:  Eur Heart J       Date:  1995-12       Impact factor: 29.983

10.  Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity.

Authors:  Urs Eriksson; Romeo Ricci; Lukas Hunziker; Michael O Kurrer; Gavin Y Oudit; Tania H Watts; Ivo Sonderegger; Kurt Bachmaier; Manfred Kopf; Josef M Penninger
Journal:  Nat Med       Date:  2003-11-16       Impact factor: 53.440

View more
  3 in total

1.  Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n.

Authors:  Michael J Coronado; Jessica E Brandt; Eunyong Kim; Adriana Bucek; Djahida Bedja; Eric D Abston; Jaewook Shin; Kathleen L Gabrielson; Wayne Mitzner; DeLisa Fairweather
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-02-10       Impact factor: 4.733

2.  Antimicrobial agents for myocarditis: target the pathway, not the pathogen.

Authors:  Lori A Blauwet; Leslie T Cooper
Journal:  Heart       Date:  2009-07-16       Impact factor: 5.994

3.  HMG-CoA Reductase Inhibitor, Simvastatin Is Effective in Decreasing Degree of Myocarditis by Inhibiting Metalloproteinases Activation.

Authors:  Monika Skrzypiec-Spring; Agnieszka Sapa-Wojciechowska; Katarzyna Haczkiewicz-Leśniak; Tomasz Piasecki; Joanna Kwiatkowska; Marzenna Podhorska-Okołów; Adam Szeląg
Journal:  Biomolecules       Date:  2021-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.